Brought to you by:
CSI announces development of IVL technology for the treatment of PAD
Cardiovascular Systems (CSI) recently announced that it has made significant progress towards the commercialization of its intravascular lithotripsy (IVL) system for the treatment of calcific peripheral arterial disease (PAD). A company press release notes that feasibility testing of a proprietary…
Europe: ESVS publishes 2022 guidelines on management of chronic venous disease of the lower limb
The European Society for Vascular Surgery (ESVS) has released 2022 clinical practice guidelines on the management of chronic venous disease (CVD) of the lower limb to update its 2015 recommendations. The document, authored by Marianne De Maeseneer, MD, a venous…
New recommendations promote ‘appropriate and effective’ use of social media in medicine
In response to a rapid augmentation of social media use in medicine over the past five years, the Society for Vascular Surgery (SVS) has published a set of recommendations on appropriate practice. The document aims to provide guidance on “how…
US IDE Aortic Research Consortium ‘pushes the envelope’ on F/BEVAR
The U.S. investigational device exemption (IDE) Aortic Research Consortium has produced the strongest data so far on the use of fenestrated/branched endovascular aneurysm repair (F/BEVAR), Andres Schanzer, MD, professor and chief of vascular surgery at the University of Massachusetts Medical School…
Our forever plague
The following is a combined and revised version of the November and December 2021 editorials on fake news and science denial published in Vascular Specialist. Supplemental information and resources have been added to assist physicians in combating science denial and…
Deadlines near for slew of awards, honors
It’s awards season at the Society for Vascular Surgery (SVS) and the SVS Foundation, with deadlines in January, February and March for many awards and honors—and two have been extended. “These awards honor both the past and the future,” said…
FDA issues updated safety communication on use of Endologix AFX endovascular grafts
The Food and Drug Administration (FDA) has issued an updated safety communication on the use of Endologix AFX endovascular grafts. This update includes a summary of information from a November 2021 meeting of the FDA’s Circulatory System Devices Panel of…
VAM travel scholarship applications available this month
Medical students and general surgery residents will be able to apply this month for travel scholarships to attend the 2022 Society for Vascular Surgery (SVS) Vascular Annual Meeting (VAM)—with the application period opening toward the end of the month. The…
SVS PAD course postponed
The new Society for Vascular Surgery (SVS) Peripheral Arterial Disease (PAD) Skills Course has been postponed amid the COVID-19 pandemic recent surge in cases, the Society has announced. The course—which had been set to run Feb. 11–12—will now take place…
Deadlines near to submit VRIC and VAM abstracts
Abstract submissions for possible presentation at the 2022 Vascular Research Initiatives Conference (VRIC) and the 2022 Vascular Annual Meeting (VAM) in Boston are due Jan. 11 and Jan. 12, respectively. Submissions for VRIC, which emphasizes basic and translational vascular science,…